Newsletter | January 25, 2023

01.25.23 -- These Top 2022 Global Bioprocessing Trends Will Affect The Industry In 2023

New Podcast Episode
Featured Editorial
Industry Insights
Have CDMO Selection Criteria Changed Over the Past Five Years?

New relationship dynamics between sponsors and CDMOs contribute to new trends appearing in the outsourced activities and services, as well as the way CDMO selection decisions are made. ISR shares how CDMO selection criteria has changed over the past five years and links the attributes to the Life Science Leader’s CMO Leadership Awards categories.

Five Dangers Of An Insecure API Supply Chain

The diversity and agility of API supply chains are key to ensuring that medicines can be manufactured and delivered to patients on time, even in the face of challenges and unforeseen circumstances.

MAM Solutions For Process And Product Control Of Biotherapeutic Proteins

With industry-leading scientific expertise and customer support, we have pioneered solutions to some of the most pressing challenges facing customers interested in adopting MAM into their organizations.

How The inSeption Group Cooperativity Program Quickly Built A Client’s Medical Writing Team

The Cooperativity Program’s goal is to help ISG clients build and strengthen their in-house departments — medical writing or otherwise — to reach their utmost potential.

Rapid Change Is Everywhere In The Biotech Industry. Meaningful Innovation Is Not.

CDMOs face the challenge of integrating novel technologies to deliver cost-effective innovation to the market. How a CDMO responds to the unexpected can determine the success or failure of a project.

The Future Of Small And Large Molecule Bioanalytics Today

To truly understand the way novel therapies function in living biological systems, learn about a new dimension of study that has become indispensable: spatial bioanalysis.

Ensuring Success In Early Biopharmaceutical Formulation Development

Biopharmaceuticals tend to be highly unstable. A pilot formulation study at the early drug substance development stage can make things considerably easier at the manufacturing stage.

mRNA Manufacturing Workflow

Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. Learn more about key objectives, considerations, and strategies in mRNA manufacturing.

Outsourced Pharma Live

Available On Demand! Throughout the year, chief editor Louis Garguilo brings together industry experts to discuss some of the biggest challenges being faced by both sponsors and CDMOs. Our archived videos can be accessed at any time by registered site users.